Literature DB >> 24909910

Building the multidisciplinary team for management of patients with hepatocellular carcinoma.

Willscott E Naugler1, Angel E Alsina2, Catherine T Frenette3, Lorenzo Rossaro4, Marty T Sellers5.   

Abstract

Optimal care of the patient with hepatocellular carcinoma (HCC) necessitates the involvement of multiple providers. Because the patient with HCC often carries 2 conditions with competing mortality risks (cancer and underlying cirrhosis), no single provider is equipped to deal with all of these patients' needs adequately. Multidisciplinary teams (MDTs) have evolved to facilitate care coordination, reassessments of clinical course, and nimble changes in treatment plans required for this complex group of patients. Providers or sites that elect to manage patients with HCC thus are increasingly aware of the need to build their own MDT or communicate with an established one. The availability of new communication technologies, such as teleconferencing or teleconsultation, offers the possibility of MDT expansion into underserved or rural areas, as well as areas such as correctional facilities. Although the availability of resources for HCC patient care varies from site to site, construction of an MDT is possible in a wide spectrum of clinical practices, and this article suggests a blueprint for assembly of such collaboration. Research strategies are needed to explain how MDTs improve clinical outcomes so that MDTs themselves can be improved.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HCC; Hepatocellular Carcinoma; Liver Cancer; Multidisciplinary Team

Mesh:

Year:  2014        PMID: 24909910      PMCID: PMC6658190          DOI: 10.1016/j.cgh.2014.03.038

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  10 in total

Review 1.  Multidisciplinary Approach to HCC Management: How Can This Be Done?

Authors:  Melissa M Gadsden; David E Kaplan
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

Review 2.  Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults.

Authors:  Christopher D Woodrell; Lissi Hansen; Thomas D Schiano; Nathan E Goldstein
Journal:  Clin Ther       Date:  2018-03-20       Impact factor: 3.393

Review 3.  Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis.

Authors:  Wei Liu; Jian-Guo Zhou; Yi Sun; Lei Zhang; Bao-Cai Xing
Journal:  J Gastrointest Surg       Date:  2015-05-06       Impact factor: 3.452

Review 4.  New concepts in embolotherapy of HCC.

Authors:  F Pesapane; N Nezami; F Patella; J F Geschwind
Journal:  Med Oncol       Date:  2017-03-16       Impact factor: 3.064

Review 5.  Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma.

Authors:  Renumathy Dhanasekaran; Jayant A Talwalkar
Journal:  Curr Gastroenterol Rep       Date:  2015-09

Review 6.  Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting.

Authors:  Cher Heng Tan; Shu-Cheng Chou; Nakarin Inmutto; Ke Ma; RuoFan Sheng; YingHong Shi; Zhongguo Zhou; Akira Yamada; Ryosuke Tateishi
Journal:  Korean J Radiol       Date:  2022-05-09       Impact factor: 7.109

Review 7.  Management of Hepatocellular Carcinoma: Current Status and Future Directions.

Authors:  Jennifer S Au; Catherine T Frenette
Journal:  Gut Liver       Date:  2015-07       Impact factor: 4.519

8.  Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice.

Authors:  Prashant Pandya; Fasiha Kanwal
Journal:  Hepatol Commun       Date:  2017-10-06

9.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.

Authors:  Tim F Greten; Ghassan K Abou-Alfa; Ann-Lii Cheng; Austin G Duffy; Anthony B El-Khoueiry; Richard S Finn; Peter R Galle; Lipika Goyal; Aiwu Ruth He; Ahmed O Kaseb; Robin Kate Kelley; Riccardo Lencioni; Amaia Lujambio; Donna Mabry Hrones; David J Pinato; Bruno Sangro; Roberto I Troisi; Andrea Wilson Woods; Thomas Yau; Andrew X Zhu; Ignacio Melero
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 13.751

10.  Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma.

Authors:  Wei Liu; Kun Wang; Quan Bao; Yi Sun; Bao-Cai Xing
Journal:  World J Surg Oncol       Date:  2016-03-02       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.